{"id":"https://openalex.org/W2139593370","doi":"https://doi.org/10.1177/1078155215583523","title":"Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions","display_name":"Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions","alternate_titles":[],"publication_year":2015,"publication_date":"2015-04-22","ids":{"openalex":"https://openalex.org/W2139593370","doi":"https://doi.org/10.1177/1078155215583523","mag":"2139593370","pmid":"https://pubmed.ncbi.nlm.nih.gov/25908647"},"language":"en","primary_location":{"id":"doi:10.1177/1078155215583523","doi":"https://doi.org/10.1177/1078155215583523","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1078155215583523","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139593370"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001739540","display_name":"Raymond Elsoueidi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210106462","display_name":"Appalachian Regional Healthcare","ror":"https://ror.org/01gf20981","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210106462"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond Elsoueidi","raw_affiliation_strings":["Department of Medicine, Appalachian Regional Healthcare Cancer Center, Hazard, KY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Appalachian Regional Healthcare Cancer Center, Hazard, KY, USA","institution_ids":["https://openalex.org/I4210106462"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049480642","display_name":"Michael J Lander","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J Lander","raw_affiliation_strings":["Department of Clinical Pharmacy, University of California, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy, University of California, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002369321","display_name":"Elie M. Richa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039303","display_name":"Stanford Cancer Institute","ror":"https://ror.org/014qe3j22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I4390039303","https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Elie M Richa","raw_affiliation_strings":["Stanford Cancer Institute, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford Cancer Institute, Stanford, CA, USA","institution_ids":["https://openalex.org/I4390039303"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111435564","display_name":"Eyob D. Adane","orcid":"https://orcid.org/0000-0002-2447-6113","observed_orcids":["https://orcid.org/0000-0002-2447-6113"]},"institutions":[{"id":"https://openalex.org/I150722199","display_name":"Ohio Northern University","ror":"https://ror.org/052963a64","country_code":"US","type":"education","lineage":["https://openalex.org/I150722199","https://openalex.org/I4210162304"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eyob D Adane","raw_affiliation_strings":["Department of Pharmacy Practice, Raabe College of Pharmacy, Ohio Northern University, Ada, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy Practice, Raabe College of Pharmacy, Ohio Northern University, Ada, OH, USA","institution_ids":["https://openalex.org/I150722199"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5002369321"],"corresponding_institution_ids":["https://openalex.org/I4390039303"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.3314,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.78120008,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"22","issue":"2","first_page":"271","last_page":"274"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":0.9869999885559082},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9380000233650208},{"id":"https://openalex.org/keywords/cutaneous-adverse-effects","display_name":"cutaneous adverse events","score":0.9419999718666077},{"id":"https://openalex.org/keywords/premedication","display_name":"premedication","score":0.8040000200271606},{"id":"https://openalex.org/keywords/metastatic-nsclc","display_name":"metastatic non-small cell lung cancer","score":0.8339999914169312},{"id":"https://openalex.org/keywords/chemotherapy-side-effects","display_name":"chemotherapy side effects","score":0.5580000281333923},{"id":"https://openalex.org/keywords/corticosteroid-prophylaxis","display_name":"corticosteroid prophylaxis","score":0.7689999938011169},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9470064640045166},{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.9285632967948914},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6977493166923523},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.6672577857971191},{"id":"https://openalex.org/C2778300832","wikidata":"https://www.wikidata.org/wiki/Q1589604","display_name":"Premedication","level":2,"score":0.6490926146507263},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5944197177886963},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5653144121170044},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5615982413291931},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4725506007671356},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4265352785587311},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.39226067066192627},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3158012926578522}],"mesh":[{"descriptor_ui":"D000068437","descriptor_name":"Pemetrexed","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1177/1078155215583523","doi":"https://doi.org/10.1177/1078155215583523","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1078155215583523","pdf_url":null,"source":{"id":"https://openalex.org/S66425452","display_name":"Journal of Oncology Pharmacy Practice","issn_l":"1078-1552","issn":["1078-1552","1477-092X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Oncology Pharmacy Practice","raw_type":"journal-article"},{"id":"pmid:25908647","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25908647","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W91920171","https://openalex.org/W1479687328","https://openalex.org/W1550111394","https://openalex.org/W1880283186","https://openalex.org/W1936937687","https://openalex.org/W1977941612","https://openalex.org/W2000480786","https://openalex.org/W2080522735","https://openalex.org/W2096074509","https://openalex.org/W2099725888","https://openalex.org/W2102627969","https://openalex.org/W2106612878","https://openalex.org/W2112621029","https://openalex.org/W2114998251","https://openalex.org/W2134667653","https://openalex.org/W2142703207","https://openalex.org/W2143034231","https://openalex.org/W2163379812","https://openalex.org/W2242726765"],"related_works":["https://openalex.org/W2964960971","https://openalex.org/W2896449067","https://openalex.org/W2292437343","https://openalex.org/W4400408086","https://openalex.org/W4205370568","https://openalex.org/W2491652081","https://openalex.org/W4251354397","https://openalex.org/W2412193446","https://openalex.org/W2309777334","https://openalex.org/W4237537376"],"abstract_inverted_index":{"Pemetrexed":[0],"(Alimta\u00ae)":[1],"is":[2,9,83],"a":[3,27,98,116,133],"novel":[4],"anti-folate":[5],"antimetabolite":[6],"agent":[7,29],"that":[8,132],"used":[10],"in":[11,31,146],"combination":[12,32],"with":[13,20,33,37,59,97,148],"cisplatin":[14,34],"for":[15,35,52],"the":[16,54,69,73,124],"treatment":[17],"of":[18,50,84,90,101,112,126,136],"patients":[19,36,93,114,147],"unresectable":[21],"malignant":[22],"pleural":[23],"mesothelioma":[24],"and":[25,72],"as":[26],"single":[28,99,134],"or":[30,40,108,119,157],"locally":[38],"advanced":[39],"metastatic":[41,91,149],"non-small-cell-lung-cancer.":[42],"Cutaneous":[43],"adverse":[44],"reactions":[45,122],"are":[46],"common":[47],"side":[48],"effects":[49],"pemetrexed":[51,107,156],"which":[53],"manufacturer":[55],"recommends":[56],"3-day":[57],"premedication":[58,81,144],"dexamethasone":[60,102,137],"4":[61],"mg":[62,104,139],"by":[63],"mouth":[64],"twice":[65],"daily-(the":[66],"day":[67,70,74],"before,":[68],"of,":[71],"after":[75],"treatment).":[76],"Patients'":[77],"adherence":[78],"to":[79,106],"this":[80],"regimen":[82,145],"concern.":[85],"We":[86],"report":[87],"14":[88],"cases":[89],"non-small-cell-lung-cancer":[92],"who":[94],"were":[95],"premedicated":[96],"dose":[100,135],"20":[103,138],"prior":[105],"pemetrexed-based":[109,158],"chemotherapy.":[110,159],"None":[111],"these":[113],"reported":[115],"grade":[117],"3":[118],"above":[120],"skin":[121],"over":[123],"course":[125],"their":[127],"treatments.":[128],"These":[129],"findings":[130],"suggest":[131],"may":[140],"be":[141],"an":[142],"alternative":[143],"non":[150],"small":[151],"cell":[152],"lung":[153],"cancer":[154],"receiving":[155]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139593370","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}
